DrugPatentWatch Database Preview
CETROTIDE Drug Profile
» See Plans and Pricing
Which patents cover Cetrotide, and what generic alternatives are available?
Cetrotide is a drug marketed by Emd Serono Inc and is included in one NDA.
The generic ingredient in CETROTIDE is cetrorelix. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cetrorelix profile page.
Summary for CETROTIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 37 |
| Clinical Trials: | 46 |
| Patent Applications: | 3,856 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CETROTIDE |
| What excipients (inactive ingredients) are in CETROTIDE? | CETROTIDE excipients list |
| DailyMed Link: | CETROTIDE at DailyMed |
Recent Clinical Trials for CETROTIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| El Shatby University Hospital for Obstetrics and Gynecology | Phase 3 |
| Assiut University | N/A |
| Royan Institute | N/A |
US Patents and Regulatory Information for CETROTIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CETROTIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | Start Trial | Start Trial |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | Start Trial | Start Trial |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | Start Trial | Start Trial |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CETROTIDE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Turkey | 200003063 | Start Trial |
| Ireland | 62744 | Start Trial |
| Hungary | 206376 | Start Trial |
| Germany | 3823590 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CETROTIDE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0299402 | C990029 | Netherlands | Start Trial | PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413 |
| 0299402 | 31/1999 | Austria | Start Trial | PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413 |
| 0299402 | 099C0031 | Belgium | Start Trial | PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
